Patents Assigned to UNIVERSITE DE DROIT ET DE SANTE DE LILLE
  • Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
    Patent number: 9913829
    Abstract: The present invention relates to the compound of formula (I) for use in the treatment of a nonsense-mutation-mediated genetic disease.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: March 13, 2018
    Assignees: UNIVERSITE DE DROIT ET DE SANTE DE LILLE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT PASTEUR DE LILLE
    Inventors: Fabrice Lejeune, Benoit Deprez, Terence Beghyn, Sara Sofia Gonzalez-Hilarion
  • Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
    Patent number: 9731005
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment of a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid, without said cationic-polysaccharide core being surrounded by any phospholipidic layer, and at least an antigen obtained from said pathogen.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: August 15, 2017
    Assignees: UNIVERSITE DE DROIT ET DE SANTE DE LILLE II, UNIVERSITE DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau
  • PHARMACEUTICAL COMPOSITION COMPRISING A SOLID NANOPARTICLE AND AT LEAST AN ANTIGEN FOR THE TREATMENT AGAINST AN INTRACELLULAR PATHOGENIC AGENT
    Publication number: 20150238598
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment in a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid without being surrounded by any phospholipidic layer and at least an antigen obtained from said pathogen.
    Type: Application
    Filed: September 13, 2013
    Publication date: August 27, 2015
    Applicants: UNIVERSITÉ DE DROIT ET DE SANTÉ DE LILLE II, UNIVERSITÉ DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau